169 related articles for article (PubMed ID: 18959436)
1. Design, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexate.
Bai KB; Láng O; Orbán E; Szabó R; Köhidai L; Hudecz F; Mezö G
Bioconjug Chem; 2008 Nov; 19(11):2260-9. PubMed ID: 18959436
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of oligotuftsin-based branched oligopeptide conjugates for chemotactic drug targeting.
Mezö G; Láng O; Jakab A; Bai KB; Szabó I; Schlosser G; Láng J; Köhidai L; Hudecz F
J Pept Sci; 2006 May; 12(5):328-36. PubMed ID: 16245264
[TBL] [Abstract][Full Text] [Related]
3. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
[TBL] [Abstract][Full Text] [Related]
4. Effect of tuftsin and oligotuftsins on chemotaxis and chemotactic selection in Tetrahymena pyriformis.
Láng O; Mezo G; Hudecz F; Kohidai L
Cell Biol Int; 2006 Jul; 30(7):603-9. PubMed ID: 16733095
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers.
Fitzpatrick JJ; Garnett MC
Anticancer Drug Des; 1995 Jan; 10(1):1-9. PubMed ID: 7695810
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence.
Mezö G; Kalászi A; Reményi J; Majer Z; Hilbert A; Láng O; Köhidai L; Barna K; Gaál D; Hudecz F
Biopolymers; 2004 Apr; 73(6):645-56. PubMed ID: 15048768
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
8. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
9. Cell uptake and trafficking behavior of non-covalent, coiled-coil based polymer-drug conjugates.
Apostolovic B; Deacon SP; Duncan R; Klok HA
Macromol Rapid Commun; 2011 Jan; 32(1):11-8. PubMed ID: 21432965
[TBL] [Abstract][Full Text] [Related]
10. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
11. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.
Rosenholm JM; Peuhu E; Bate-Eya LT; Eriksson JE; Sahlgren C; Lindén M
Small; 2010 Jun; 6(11):1234-41. PubMed ID: 20486218
[TBL] [Abstract][Full Text] [Related]
12. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
Hu J; Su Y; Zhang H; Xu T; Cheng Y
Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents.
Wei WH; Fountain M; Magda D; Wang Z; Lecane P; Mesfin M; Miles D; Sessler JL
Org Biomol Chem; 2005 Sep; 3(18):3290-6. PubMed ID: 16132091
[TBL] [Abstract][Full Text] [Related]
14. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
15. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
Varghese OP; Sun W; Hilborn J; Ossipov DA
J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
[TBL] [Abstract][Full Text] [Related]
16. Solid phase synthesis and biological activity of tuftsin conjugates.
Kukowska-Kaszuba M; Dzierzbicka K; Serocki M; Skladanowski A
J Med Chem; 2011 Apr; 54(7):2447-54. PubMed ID: 21425770
[TBL] [Abstract][Full Text] [Related]
17. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
18. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol.
Calderón M; Graeser R; Kratz F; Haag R
Bioorg Med Chem Lett; 2009 Jul; 19(14):3725-8. PubMed ID: 19553109
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and in vitro evaluation of methotrexate conjugated fluorescent carbon nanoparticles as drug delivery system for human lung cancer targeting.
Ajmal M; Yunus U; Matin A; Haq NU
J Photochem Photobiol B; 2015 Dec; 153():111-20. PubMed ID: 26398818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
